DNA repair mechanisms are crucial in maintaining genomic stability by correcting DNA lesions. In cancer cells, these mechanisms can be defective, leading to increased accumulation of mutations and cancer progression. However, these defects can also be therapeutic targets. Inhibiting specific DNA repair pathways can increase the sensitivity of cancer cells to DNA damaging agents, thereby enhancing treatment efficacy. Understanding the interplay between DNA repair and damage is key to developing new therapeutic strategies.
